TrimRx's Blog
Wegovy Pancreatitis — Risk Factors & Warning Signs
Wegovy pancreatitis risk is rare (0.2–0.7% of users) but serious. Understand symptoms, pre-existing risk factors, and when to seek immediate care.
Wegovy Heart Palpitations — Causes, Risks & What to Do
Wegovy heart palpitations occur in 5–8% of patients during dose titration. Learn the mechanism, when to worry, and how to manage cardiovascular side
Wegovy Gallbladder Risks — What Patients Need to Know
Wegovy increases gallbladder disease risk through rapid weight loss and GLP-1 receptor effects. Learn the mechanisms, symptoms to watch for, and
Wegovy Sulfur Burps — Causes and Relief | TrimRX Blog
Wegovy sulfur burps stem from slowed gastric emptying and gut microbiome shifts. Learn immediate relief strategies and prevention tactics from medical
Wegovy Kidney Effects — Protection, Risks & What to Know
Wegovy shows kidney-protective effects in clinical trials, reducing proteinuria by 30% in diabetic patients — but dosing caution required in advanced CKD.
Wegovy Liver Effects — What Patients Need to Know
Wegovy shows meaningful liver fat reduction in clinical trials — reducing hepatic steatosis by up to 30% — but liver enzyme monitoring is still essential.
Wegovy Butt — What Causes It and What You Can Do
Wegovy butt refers to sagging gluteal tissue after rapid weight loss on semaglutide. Here’s the mechanism behind it and what patients can do.
Wegovy Face — What It Is, Why It Happens & Solutions
Wegovy face refers to facial volume loss during rapid weight reduction on GLP-1 therapy — this explains the biological cause and what patients can do
Wegovy Dizziness — Causes, Duration & When to Act
Wegovy dizziness affects 10–15% of patients during dose titration. Learn why it happens, how long it lasts, and when medical attention is required.
